Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.103.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.92 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.101 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.57NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.60NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.39.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.134NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.2 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.82 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.466.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.78NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used